Company intelligence / Profile preview

Pharmaxo

Corsham, England, United Kingdompharmaxo.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Pharmaxo—now operating as part of Icon Group—is a leading UK-based pharmaceutical manufacturer and clinical homecare provider. The company specializes in aseptic manufacturing of medicines including chemotherapy and immunotherapies, delivering these treatments both to hospitals and directly to patients’ homes. It works closely with the NHS to support out-of-hospital care for cancer patients, those with rare diseases or chronic conditions. In July 2024 it was acquired by Icon Group to expand integrated cancer care capacity across the UK.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Small moleculeBiologicProteinMonoclonal antibody
Industry: Contract Manufacturing Organization

Partnerships

NHSNuffield Health

Beyond the preview

Go deeper on Pharmaxo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaxo.

Explore the full profile